Skip navigation

Refine by Type

Results 1 - 8 of 8 for RANIBIZUMAB
  1. Ranibizumab is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye ... to read, drive, or perform other daily activities). Ranibizumab is in a class of medications called vascular ...
  2. Clinical Trials for Dry AMD (Macular Degeneration Partnership)  
    ... Lucentis For Dry AMD The clinical trial, Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (PREVENT) is ... The study will determine whether quarterly injections of Ranibizumab (Lucentis) may prevent eyes with dry AMD from ...
  3. ... Drug Administration (FDA) approved a promising new drug—ranibizumab (marketed as Lucentis) — for treatment of neovascular agerelated ... second drug is considerably cheaper for patients than ranibizumab. "The good news for patients is that there ...
  4. If I Had - Macular Degeneration Video (Insidermedicine)  
    ... well. There’s several drugs that are out there – ranibizumab was tested in large clinical trials and showed ...
  5. NIH: Turning Discovery Into Health From the National Institutes of Health (National Institutes of Health) - PDF  
    ... advanced AMD. The most recent FDA-approved drug, ranibizumab injection, blocks vessel leakage and in many cases ...
  6. ... which are injected into the eye, are Lucentis (ranibizumab) and Avastin (bevacizumab). Results indicate that the two ...
  7. ... which are injected into the eye, are Lucentis (ranibizumab) and Avastin (bevacizumab). NEI is also supporting AREDS2 ...
  8. ... this alarming statistic. What's New: Two new drugs, ranibizumab (Lucentis) and bevacizumab (Avastin) are being used to ...